ConductScience.org, home

Paper32550804

Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an Ehrlich ascites tumor model.

Singh M and 12 others. Saudi Pharm J, 2020. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an Ehrlich ascites tumor model. Papers, record 32550804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32550804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an Ehrlich ascites tumor model.
PubMed
Journal
Saudi Pharm J
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2020-09-28
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh MManvi
2Hassan NNazia
3Verma DDevina
4Thakur PPragya
5Panda BPBibhu Prasad
6Panda AKAmulya Kumar
7Sharma RKRakesh Kumar
8Mirza AAamir
9Mansoor SSheikh
10Alrokayan SHSalman H
11Khan HAHaseeb A
12Ahmad PParvaiz
13Iqbal ZZeenat

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125309524Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.Front Microbiol2014https://conductscience.org/library/papers/25309524PubMed
212695020Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres.Int J Pharm2003https://conductscience.org/library/papers/12695020PubMed
37105004Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.Cancer Res1982https://conductscience.org/library/papers/7105004PubMed
413129826Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.J Drug Target2003https://conductscience.org/library/papers/13129826PubMed
516978810Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.Int J Pharm2007https://conductscience.org/library/papers/16978810PubMed
610802410Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.Int J Pharm2000https://conductscience.org/library/papers/10802410PubMed
716508146Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in Ehrlich ascites carcinoma bearing mice.Biol Pharm Bull2006https://conductscience.org/library/papers/16508146PubMed
818556649Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo.FASEB J2008https://conductscience.org/library/papers/18556649PubMed
926548664Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential.Drug Deliv2016https://conductscience.org/library/papers/26548664PubMed
1011274752PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.J Control Release2001https://conductscience.org/library/papers/11274752PubMed
1119160022Hydrogel-magnetic nanoparticles with immobilized L-asparaginase for biomedical applications.J Mater Sci Mater Med2009https://conductscience.org/library/papers/19160022PubMed
1229626721Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy.Colloids Surf B Biointerfaces2018https://conductscience.org/library/papers/29626721PubMed
1324355618Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs.Int J Biol Macromol2014https://conductscience.org/library/papers/24355618PubMed
144912983The immunodepressive activity of N-diazoacetylglycine amide in some transplantation systems.Transplantation1970https://conductscience.org/library/papers/4912983PubMed
1520524422Kinetic modeling on drug release from controlled drug delivery systems.Acta Pol Pharm2010https://conductscience.org/library/papers/20524422PubMed
1621042421Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model.Int J Nanomedicine2010https://conductscience.org/library/papers/21042421PubMed
1720824725L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.Cancer2011https://conductscience.org/library/papers/20824725PubMed
182423675Soluble asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity.J Pharm Pharmacol1986https://conductscience.org/library/papers/2423675PubMed
1925589205Anticancer activity of fungal L-asparaginase conjugated with zinc oxide nanoparticles.J Mater Sci Mater Med2015https://conductscience.org/library/papers/25589205PubMed
2011929760
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.
Blood2002https://conductscience.org/library/papers/11929760PubMed

See all 42 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
37285001Polyamidoamine Dendrimers Functionalized with ZnO-Chitosan Nanoparticles as an Efficient Surface for L-asparaginase Immobilization.Appl Biochem Biotechnol2024https://conductscience.org/library/papers/37285001PubMed
36678770Hybrid Silica-Coated PLGA Nanoparticles for Enhanced Enzyme-Based Therapeutics.Pharmaceutics2022https://conductscience.org/library/papers/36678770PubMed
35744957Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.Molecules2022https://conductscience.org/library/papers/35744957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32550804

GET https://conductscience.org/api/papers/v1/32550804/references?page=2